Petco Health & Wellness Company, Inc. (WOOF)
Petco Health & Wellness Company, Inc. (WOOF)
| Cash Flow | 2026-05-02 | 2026-01-31 | 2025-11-01 | 2025-08-02 |
|---|---|---|---|---|
| Revenue | 1,496,732 | 1,515,128 | 1,464,411 | 2,981,928 |
| Cost of sales | 922,307 | 934,358 | 895,396 | 1,826,641 |
| Advertising and marketing expenses | 39,087 | 46,336 | 38,063 | 73,367 |
| Stock compensation - general and administrative | NaN | NaN | 7,043 | 17,979 |
| Stock compensation | 9,342 | 32,188 | NaN | NaN |
| Other general and administrative expenses | 501,370 | 495,412 | 494,713 | 1,004,560 |
| Goodwill impairment | NaN | 0 | NaN | NaN |
| Interest income | 1,497 | 2,223 | 1,814 | 2,268 |
| Interest expense | 32,785 | 31,581 | 32,827 | 66,791 |
| Loss on extinguishment and modification of debt | -11,840 | -565 | NaN | NaN |
| Other non-operating income | NaN | 0 | NaN | NaN |
| Income tax expense | 2,199 | 11,301 | -6,276 | 1,241 |
| Income from equity method investees | 5,555 | 6,793 | 4,871 | 8,694 |
| Net loss | -15,146 | -2,575 | 9,330 | 2,311 |
| Depreciation and amortization | 49,041 | 48,244 | 49,817 | 98,649 |
| Amortization of debt discounts and issuance costs | 1,337 | 1,262 | 1,261 | 2,499 |
| Provision for deferred taxes | 288 | 17,100 | -1,163 | 1,113 |
| Equity-based compensation | 9,451 | 7,278 | 7,163 | 18,209 |
| Impairments, write-offs and losses on sale of fixed and other assets | NaN | NaN | 155 | 522 |
| Loss on extinguishment and modification of debt | -11,840 | -565 | NaN | NaN |
| Income from equity method investees | 5,555 | 6,793 | 4,871 | 8,694 |
| Amounts reclassified out of accumulated other comprehensive loss | -51 | -5 | 148 | 413 |
| Goodwill impairment | NaN | 0 | NaN | NaN |
| Non-cash operating lease costs | 103,080 | 103,515 | 103,292 | 205,005 |
| Other non-operating income | NaN | 0 | 0 | 0 |
| Receivables | -8,884 | 2,912 | 8,492 | -5,783 |
| Merchandise inventories | 42,702 | -27,686 | 9,390 | -44,823 |
| Prepaid expenses and other assets | 8,299 | -3,255 | -7,050 | 9,487 |
| Accounts payable and book overdrafts | 30,577 | 20,129 | 6,570 | -69,691 |
| Accrued salaries and employee benefits | -46,362 | 42,967 | -19,509 | -26,729 |
| Accrued expenses and other liabilities | 11,559 | -5,041 | 15,520 | 14,508 |
| Operating lease liabilities | -139,677 | -97,192 | -67,528 | -206,414 |
| Other long-term liabilities | 664 | -3,294 | 1,033 | -1,556 |
| Net cash used in operating activities | -30,969 | 153,522 | 90,090 | 70,438 |
| Cash paid for fixed assets | 38,153 | 37,137 | 29,444 | 60,516 |
| Cash paid for acquisitions, net of cash acquired | NaN | NaN | 0 | 0 |
| Cash paid for investment | NaN | NaN | 0 | NaN |
| Proceeds from investment | NaN | NaN | 0 | 0 |
| Insurance recoveries | 230 | NaN | NaN | NaN |
| Proceeds from sale of assets | 0 | 0 | 116 | 2,425 |
| Cash received from partial surrender of officers' life insurance | 74 | NaN | 0 | 0 |
| Net cash used in investing activities | -37,849 | -37,137 | -29,328 | -58,091 |
| Borrowings under long-term debt agreements | 1,500,000 | NaN | 0 | 0 |
| Repayments of long-term debt | 1,500,000 | 95,250 | 0 | 0 |
| Debt refinancing costs and original issue discount | 28,442 | NaN | 0 | 0 |
| Payments for finance lease liabilities | 1,110 | 1,181 | 1,181 | 3,252 |
| Proceeds from employee stock purchase plan and stock option exercises | 1,008 | 939 | 740 | 1,998 |
| Tax withholdings on stock-based awards | 4,094 | 904 | 630 | 3,026 |
| Proceeds from issuance of common stock | NaN | NaN | 0 | 0 |
| Net cash used in financing activities | -32,638 | -96,396 | -1,071 | -4,280 |
| Net decrease in cash, cash equivalents and restricted cash | -101,456 | 19,989 | 59,691 | 8,067 |
| Cash, cash equivalents and restricted cash at beginning of period | 269,412 | 249,423 | 181,665 | NaN |
| Cash, cash equivalents and restricted cash at end of period | 167,956 | 269,412 | 249,423 | NaN |